| Literature DB >> 35601363 |
Ostap Lishchynskyi1,2, Yana Shymborska1,3, Yurij Stetsyshyn1,3, Joanna Raczkowska3, Andre G Skirtach2, Taras Peretiatko4, Andrzej Budkowski3.
Abstract
Viruses pose a serious threat to human health and society in general, as virus infections are one of the main causes of morbidity and mortality. Till May 2022, over 513 million people around the world have been confirmed to be infected and more than 6.2 million have died due to SARS-CoV-2. Although the COVID-19 pandemic will be defeated in the near future, we are likely to face new viral threats in the coming years. One of the important instruments to protect from viruses are antiviral surfaces, which are essentially capable of limiting their spread. The formulation of the concept of antiviral surfaces is relatively new. In general, five types of mechanism directed against virus spread can be proposed for antiviral surfaces; involving: direct and indirect actions, receptor inactivation, photothermal effect, and antifouling behavior. All antiviral surfaces can be classified into two main types - passive and active. Passive antiviral surfaces are based on superhydrophobic coatings that are able to repel virus contaminated droplets. In turn, viruses can become biologically inert (e.g., blocked or destroyed) upon contact with active antiviral surfaces, as they contain antiviral agents: metal atoms, synthetic or natural polymers, and small molecules. The functionality of antiviral surfaces can be significantly improved with additional properties, such as temperature- or pH-responsivity, multifunctionality, non-specific action on different virus types, long-term application, high antiviral efficiency and self-cleaning.Entities:
Keywords: Antiviral agents; Coatings; Nanoparticles; Surfaces; Viruses
Year: 2022 PMID: 35601363 PMCID: PMC9113772 DOI: 10.1016/j.cej.2022.137048
Source DB: PubMed Journal: Chem Eng J ISSN: 1385-8947 Impact factor: 16.744
Fig. 1Interaction of hemagglutinin (HA) of the influenza A virus with the receptor on the cell surface. Top: left: model of the virion structure of the influenza A virus; right: structure of N-acetylneuraminic acid, a type of sialic acid. Bottom: left: model of structure of hemagglutinin, which is the trimer, all monomers of which consists of two subunits (HA1 and HA2); right: the receptor binding site is magnified and reoriented to depict structural features and conserved residues in the binding pocket, along with the location occupied by bound sialic acid, shown in green. All numbers based on H3 subtype of hemagglutinin [19], [20], [21] (all panels were adapted with permission form Refs. [19], [20], [21]).
Fig. 2Model of the virion structure of SARS-CoV-2 (top) and conformational changes in the spike ectodomain during membrane fusion (bottom). Bottom: left: top view of prefusion SARS-CoV-2 S. The conformational changes in adjacent N-terminal domains NTDs (NTD1 and NTD2) as the receptor-binding domain (RBD) of protomer shifts to the upward position are indicated with arrows; middle-left: side view of prefusion SARS-CoV-2 S with two RBDs in the down conformation (RBMs (receptor-binding motif) hidden) and one RBD in the upward conformation (RBM exposed), bound to the ACE2 receptor; middle-right: side view of postfusion SARS-CoV-2 S with S1 (receptor-binding subunit of spike glycoptotein) shed and S2 (membrane-anchored subunit of spike glycoptotein) subunits elongated towards the host cell membrane with FP (fusion peptide) inserted; right: side view of postfusion SARS-CoV-2 S after a collapse that allowed HR2 (heptad repeats 2) to form a six-helix bundle with HR1 (heptad repeats 1), resulting in fusion of the viral membrane with the host cell membrane [22], [23] (all panels were adapted with permission form Refs. [22], [23]).
Fig. 3Types of antiviral mechanisms and classification of active and passive antiviral surfaces.
Fig. 4General scheme of fabrication of the passive antiviral surfaces (a); fomite formation for typical surfaces, and prevention of fomite formation for superhydrophobic surfaces (b).
Fig. 5Fabrication of nanocomposite coating based on polymers and metallic nanoparticles (a). Typical images of Ag nanoparticles incorporated in P4VP coatings, provided by scanning electron microscopy (b) and atomic force microscopy (c).
Metal-based antiviral surfaces.
| Coating Materials | Virus | References |
|---|---|---|
| Cu and Cu2O | HCoV-229E | |
| AgNPs with an aqueous extract | influenza A virus (strain A/PR/8) | |
| Silver nanoparticles (AgNPs) | Chikungunya virus | |
| Ag2O/AgO NPs | Herpes Simplex virus (HSV-1) | |
| AgNPs | HIV-1 | |
| AgNPs (10–80 nm, with or without polysaccharide coating | Monkeypox virus Zaire strain (MPOX-Z | |
| Ag-NPs coated polyurethane condom | HIV-1 and herpes simplex virus (HSV) | |
| Silver nanoparticles (AgNP) | SARS-CoV-2 | |
| Ag/SiO2 nanoparticle film | SARS-CoV-2 | |
| Copper or stainless steel | Influenza A virus | |
| Alloys, containing over 60% copper | Murine norovirus (MNV-1) | |
| Cu2O | bacteriophages T4 and Qβ | |
| Copper iodide (CuI) particles | A/California/07/09 (H1N1) pdm (A/H1N1pdm) | |
| Copper oxide particles | Human immunodeficiency viruses (HIV-1), human influenza A virus (H1N1) and avian influenza virus (H9N2) | |
| Cuprous oxide Nanoparticles CuO-NPs | Hepatitis C Virus (HCV) | |
| Copper surface | Human coronavirus 229E (HuCoV-229E) | |
| CuO nanoparticle | SARS-CoV-2 | |
| ZnO nanostructures | Herpes simplex virus (HSV-1) | |
| TiO2- and TiO2–Ag (Ti:Ag atomic ratio 1:0.04)-coated ceramic tiles | SARS-CoV-2 | |
| TiO2 nano-colloids | Newcastle virus (NDV) | |
| TiO2 particles | MS-2 phage and Escherichia coli | |
| TiO2 | Murine norovirus, HSV-1, bacteriophage MS2, Hepatitis B, human rotavirus strain Odelia, a simian rotavirus strain SA11, human astrovirus serotype 1 (HAstV-1), and FCV strain F4 |
Fig. 6Main mechanisms of the antiviral actions of metal-based coatings.
Fig. 7Photothermal effect (for semiconductors and polymers) of the surfaces nanofunctionalized against viruses.
Fig. 8Physically adsorbed (a) and grafted brush (b) antiviral coatings of hydrophobic polycations based on N,N-dodecyl methyl-polycations. Hypothetical scheme (c) of the antiviral action of hydrophobic polycation.
Fig. 9Biopolymers with potential to manufacture antiviral coatings.
Fig. 10Small molecules with potential to fabricate antiviral coatings.